NCT01667718View on ClinicalTrials.gov

Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Functional DyspepsiaPeptic Ulcer
Interventions
DRUG

Bismuth

Bismuth 220mg b.i.d for 2 weeks

DRUG

Lansoprazole

Lansoprazole 30 mg b.i.d.for 2 weeks

DRUG

Levofloxacin

Levofloxacin 0.5 q.d. for 2 weeks

DRUG

Amoxicillin

Amoxicillin 1 g b.i.d. for 2 weeks

Trial Locations (1)

200127

Shanghai Jiao-Tong University School of Medicine Renji Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01667718 - Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment | Biotech Hunter | Biotech Hunter